Methods for breast cancer risk assessment
US11072830B2 · kind B2 · utility
0Cited by
4References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2017 |
| Grant date | Jul 27, 2021 |
| Priority date | — |
| Expiry date | Nov 15, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/172
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to methods and systems for assessing the overall risk of a human female subject for developing a breast cancer phenotype. In particular, the present invention relates to combining clinical risk assessment and genetic risk assessment to improve risk analysis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.